Comparison of patients achieving treatment success with a glucagon‐like peptide‐1 receptor agonist for weight management between primary care provider and pharmacist co‐managed patients

Documenti analoghi

• Identifying ideal pharmacist‐to‐patient ratios for the successful provision of clinical pharmacy services
  di: Jay L. Martello, et al.
  Pubblicazione: (2024)
• Real‐world observations of using compounded GLP ‐1 ±  GIP agonists within a clinical pharmacist‐managed cardiometabolic clinic
  di: Shannon W. Finks, et al.
  Pubblicazione: (2025)
• Evaluation of hemoglobin A1c reduction in Hispanic patients versus non‐Hispanic patients with type 2 diabetes managed by a clinical pharmacist
  di: Mayela Warner, et al.
  Pubblicazione: (2025)
• Comparative analysis of glycemic outcomes following implementation of a pharmacist‐led insulin management service in postoperative cardiothoracic surgery patients
  di: Sydney Kermeen, et al.
  Pubblicazione: (2025)
• Retrospective cohort study of ambulatory care pharmacist interventions’ impact on incidence of therapeutic response in anxiety and depression
  di: Ashlyn M. Kiebach, et al.
  Pubblicazione: (2024)